Src型チロシンキナーゼによるチロシンリン酸化シグナリングを介したアポトーシス抑制機構の解明 by MORII, Mariko & 森井, 真理子
 1 
 
Tyrosine phosphorylation signaling 
in Src-mediated suppression of apoptosis 
 
(Src型チロシンキナーゼによるチロシンリン酸化 
シグナリングを介したアポトーシス抑制機構の解明) 
 
 
 
 
 
 
 
2017 
 
Mariko Morii 
  
 2 
CONTENTS 
  
Introduction ·················································································· 3 
 
Materials and Methods ···································································· 5 
 
Results ························································································· 8 
 
Discussion ···················································································· 13 
 
References ··················································································· 15 
 
Figures ························································································ 21 
 
Tables ························································································· 25 
 
Main Publication ··········································································· 28 
 
Examiners ··················································································· 29 
 
Acknowledgements ········································································ 30 
  
  
 
 
 
  
 3 
Introduction 
 
Protein-tyrosine phosphorylation is one of the key posttranslational modifications that 
regulate various cellular events, such as cell proliferation, cell adhesion, and differentiation 
(Hubbard and Till, 2000; Hunter, 2009) (Figure 001). Human genome encodes 518 protein 
kinases, including 428 serine and threonine kinases and 90 tyrosine kinases (Manning et al., 
2002). In contrast to receptor-type tyrosine kinases, the functions of non-receptor-type 
tyrosine kinases depend on their subcellular localizations (Ullrich and Schlessinger, 1990). 
Src-family tyrosine kinases, which are non-receptor-type kinases, consist of 
proto-oncogene products and structurally related proteins, such as c-Src, Lyn, and Fyn 
(Brown and Cooper, 1996; Thomas and Brugge, 1997) (Figure 002). Multiple members of 
Src-family kinases are expressed in many cell types and are involved in individual and 
overlapping signaling pathways (Brown and Cooper, 1996; Thomas and Brugge, 1997). It is 
generally accepted that Src-family kinases are predominantly located at the cytoplasmic face 
of the plasma membrane through posttranslational palmitoylation and myristoylation, but in 
fact, appreciable fractions are found in a variety of intracellular locations, such as lysosomes, 
late endosomes, the Golgi apparatus, and the nucleus (Kaplan et al., 1992; Ley et al., 1994; 
Möhn et al., 1995; Bijlmakers et al., 1997; Cans et al., 2000; Yamaguchi et al., 2001; 
Kasahara et al., 2004; Kasahara et al., 2007a; Kasahara et al., 2007b; Moorhead et al., 2007; 
Sato et al., 2009; Obata et al., 2010; Honda et al., 2016).  
We have shown that Lyn, a member of Src-family kinases, is imported into and rapidly 
exported from the nucleus (Ikeda et al., 2008), and that nuclear tyrosine phosphorylation 
plays a role in global changes of chromatin structure and histone modifications (Yamaguchi 
et al., 2001, Takahashi et al., 2009; Aoyama et al., 2011; Kubota et al., 2015). To explore the 
roles of protein-tyrosine phosphorylation in cell functions, we recently performed 
phosphoproteomic analyses (Aoyama et al., 2013; Kubota et al., 2013) and identified novel 
roles for tyrosine phosphorylation of nuclear proteins, such as the transcription factors JunB 
(Yamaguchi et al., 2015) and FoxA1 (Yamaguchi et al., 2016), the heterochromatin protein 
KAP1/TIF1ß/TRIM28 (Kubota et al., 2013), and the chromatin-associated protein AKAP8 
(Kubota et al., 2015). 
Src-family kinases have been reported to suppress apoptosis by upregulating 
anti-apoptotic genes (Gillet et al., 1995 Johnson et al., 2000) and downregulating 
proapoptotic genes (Reginato et al., 2005; Lopez et al., 2012). Although Src-family kinases 
are well known as an activator of the major downstream pathways involved in growth and 
survival signaling, such as the Ras-mitogen-activated-protein-kinase (Ras–MAPK) pathway, 
the phosphatidylinositol-3-kinase-Akt (PI3K-Akt) pathway, and the STAT3 pathway (Kulik et 
al., 1997; Bonni et al., 1999; Martin, 2001; Shen et al., 2001), it was reported that caspase-8 
and the growth arrest and DNA damage protein 34 (GADD34) are associated with 
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suppression of apoptosis through tyrosine phosphorylation mediated by Src-family kinases 
(Grishin et al., 2001; Cursi et al., 2006). Despite the significance of Src-family kinases in 
suppression of apoptosis, the mechanism of Src-mediated suppression of apoptosis remains to 
be elucidated. 
In this study, I identify Ku70 as a substrate of Src-family kinases involved in apoptosis 
signaling. Inhibition of the kinase activity of endogenous Src-family kinases enhances the 
level of apoptosis upon apoptotic stimulation. Phosphorylation of Ku70 at Tyr-530 by 
Src-family kinases decreases acetylation of Ku70, resulting in suppression of apoptosis. My 
results demonstrate a novel role of Ku70’s tyrosine phosphorylation in suppression of 
apoptosis. 
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Materials and Methods 
Plasmids—The sequences of the primers used in this study are shown (Table 1, 2). To 
construct myc-tagged wild-type Ku70 (myc-Ku70-wt), the BamHI and XhoI sites were 
created at the both ends of human wild-type Ku70 (Ku70-wt; Open Biosystems) by PCR. 
Ku70-wt was inserted into the BamHI-XhoI site of the myc-pcDNA3 vector, a myc tag vector 
(Aoyama et al., 2015). The Tyr to Phe mutant of Ku70 (myc-Ku70-YF) was created by PCR 
using Ku70-wt as a template. The Tyr to Glu mutant of Ku70 (myc-Ku70-YE) was created by 
PCR using Ku70-wt as a template. Short hairpin RNA (shRNA)-resistant (shR) Ku70 
(Ku70/shR) constructs were made by mutation of the shKu70-CDS target site by PCR using 
Ku70 as a template. pcDNA4/TO/puro/myc-Ku70-wt/shR or its mutants were constructed as 
follows: the BamHI–XhoI fragment of pcDNA3/myc-Ku70-wt/shR, 
pcDNA3/myc-Ku70-YF/shR, or pcDNA3/myc-Ku70-YE/shR was subcloned into the 
myc-pcDNA4/TO/puro vector (Kubota et al., 2015). pEBmulti/puro/myc-Ku70-wt or 
pEBmulti/puro/myc-Ku70-YF was constructed as follows: the XhoI and NotI sites were 
created at the both ends of pcDNA3/myc-Ku70 by PCR, and the XhoI-NotI fragment of the 
PCR product was subcloned into the episomal pEBmulti/puro vector (Yuki et al., 2015). Bax 
was generated by PCR from HeLa cell cDNAs, and the EcoRI-XhoI fragment of the PCR 
product was subcloned into the EcoRI-XhoI site of the pcDNA3/Flag vector (Kubota et al., 
2013), resulting in the construction of Flag-tagged Bax (Flag-Bax). Intact Lyn and Lyn 
tagged with a nuclear localization signal (NLS-Lyn) was constructed from cDNA encoding 
human wild-type Lyn (Yamanashi et al., 1987; provided by T. Yamamoto) as described (Sato 
et al., 2009; Takahashi et al., 2009). Intact c-Src and HA-tagged c-Src (c-Src-HA) were 
constructed from cDNA encoding human wild-type Src (Bjorge et al., 1995; provided by D. J. 
Fujita) as described (Sato et al., 2009; Takahashi et al., 2009). HA-tagged, kinase-dead 
c-Src(K298R) [c-Src(KD)] was constructed as described previously (Fessart et al., 2005; 
provided by S.A. Laporte). Intact Fyn was constructed from cDNA encoding human 
wild-type Fyn (Tezuka et al., 1999; provided by T. Yamamoto) as described (Sato et al., 2009; 
Takahashi et al., 2009). The nucleotides for shRNA (Table 3) were annealed and subcloned 
into the BglII-XbaI site of the pENTR4/H1 vector (provided by H. Miyoshi) (Nakayama et al., 
2009; Obata et al., 2010; Morii et al., 2015). The EBNA1-based episomal pEBmulti/neo/H1 
vector, which encodes the H1 promoter and a neomycin-resistant gene, was generated from 
the pEBmulti/neo vector by replacing the CAG promoter with the H1 promoter as described 
(Kubota et al., 2015, Hasegawa et al., 2014). pEBmulti/neo/H1-sh(c-Src) was constructed as 
follows: the SpeI fragment of the PCR product was subcloned into the SpeI site of the 
pEBmulti/neo vector (Hasegawa et al., 2014).  
 
Cells and cell culture—Cells (Table5) were cultured in Iscove’s modified Dulbecco’s 
medium (IMDM) containing 5% bovine serum (BS). To establish a stable Ku70-knockdown 
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cell line (HeLa S3/shKu70), HeLa S3 cells were cotransfected with pENTR4/H1/shKu70 and 
a plasmid containing the hygromycin resistant gene, and selected in 250 µg/ml hygromycin. 
To establish stable cell lines for tetracycline-inducible myc-Ku70-wt, myc-Ku70-YF, or 
myc-Ku70-YE expression, HeLa S3/TR cells (Aoyama et al., 2011) transfected with 
pcDNA4/TO/puro/myc-Ku70-wt/shR, pcDNA4/TO/puro/myc-Ku70-YF/shR, or 
pcDNA4/TO/puro/myc-Ku70-YE/shR were selected in 350 ng/ml puromycin. Expression of 
myc-Ku70-wt, myc-Ku70-Y530F, or myc-Ku70-Y530E was induced by the addition of 1 
µg/ml doxycycline, a tetracycline derivative. To stably express myc-Ku70-wt or 
myc-Ku70-YF in HeLa S3/shKu70 cells, cells transfected with pEBmulti/puro/myc-Ku70-wt 
and pEBmulti/puro/myc-Ku70-Y5F were selected in 1.5 µg/ml puromycin. To generate 
c-Src-knockdown cells, HeLa S3 cells transfected with pEBmulti/neo/H1 or 
pEBmulti/neo/H1-sh(c-Src) were selected in 0.5-1 mg/ml G418. To inhibit Src-mediated 
tyrosine phosphorylation, cells were treated with 20 µM PP2 or 10 µM SU6656.  
 
Western blotting, Immunoprecipitation and Immunofluorescence— Antibodies used in 
this study are shown (Table 4). Western blotting was performed with enhanced 
chemiluminescence (Millipore) as described previously (Kasahara et al., 2004; Aoyama et al., 
2013; Kubota et al., 2015). Immunoprecipitation was performed as described previously 
(Mera et al., 1999; Matsuda et al., 2006; Obata et al, 2010; Ikeda et al., 2008; Aoyama et al., 
2015). To detect tyrosine phosphorylation of Ku70, cells were suspended in SDS lysis buffer 
(0.1% SDS, 50 mM Tris-HCl, pH 7.5, 10 mM Na3VO4, 10 mM unbuffered HEPES, 4 µg/ml 
aprotinin, 1.6 µg/ml pepstatin A, 4 µg/ml leupeptin, 1 mM EDTA, and 1 mM PMSF). Then, 
Triton X-100 was added to the cell lysates at a final concentration of 0.5%. After 
centrifugation, the cell lysates were subjected to immunoprecipitation. To detect tyrosine 
phosphorylation of endogenous Ku70, cells were treated with pervanadate. Pervanadate (10 
mM) was prepared in Dulbecco’s phosphate-buffered saline (D-PBS) for 5 min at 4°C from a 
100-mM sodium orthovanadate (Na3VO4) solution and 30% hydrogen peroxide at final 
concentrations of 10 mM and 0.1%. Excess hydrogen peroxide was eliminated by adding 
catalase (Wako Pure Chemical Industries, Osaka) for 5 min at room temperature (Huyer et al., 
1997). The pervanadate solution was immediately added to culture medium, and then cells 
were treated with 0.1 or 0.5 mM pervanadate for 30 min. To detect acetylation levels of Ku70, 
cells were lysed in PBS containing 1% Triton X-100, 4 µg/ml aprotinin, 1.6 µg/ml pepstatin 
A, 4 µg/ml leupeptin, 1 mM EDTA, 1 mM PMSF, and 1 µM TSA. Immunofluorescence 
staining was performed as described previously (Kasahara et al., 2004; Nakayama et al., 
2012). In brief, cells fixed in D-PBS containing 4% paraformaldehyde for 20 min were 
permeabilized in PBS containing 0.1% saponin and 3% bovine serum albumin at room 
temperature (Tada et al., 1999). To detect Ku70, cells fixed in D-PBS containing 4% 
paraformaldehyde for 20 min were extracted in D-PBS containing 0.05% Triton X-100 for 5 
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min, and then blocked in D-PBS containing 0.1% saponin and 3% bovine serum albumin at 
room temperature. Confocal images were obtained using a Fluoview Fv500 confocal laser 
scanning microscope with a 20 x 1.00 NA or 40 x 1.00 NA objective (Olympus, Tokyo), as 
described (Aoyama et al., 2011; Nakayama et al., 2012). Composite figures were prepared 
using GIMP 2.6.2 and Illustrator 16.0.  
 
Apoptosis assay—For UV irradiation, cells were treated with UV light using a CL-1000 
UV crosslinker (UVP LLC) after removal of medium, and cultured in fresh medium for 
10-12h. For Adriamycin treatment, cells were incubated with culture medium containing 1 
μg/ml Adriamycin (Wako Pure Chemical Industries, Osaka) for the indicated times. Cells 
were stained with anti-cleaved caspase-3 antibody for detection of caspase-3 activation or 
with propidium iodide for detection of nuclear condensation/fragmentation. The percentages 
of apoptotic cells were measured as the ratio of the number of apoptotic cells to the total 
number of cells from more than three randomly selected fields.  
 
In vitro kinase assay—Cell lysates were prepared in Triton X-100 lysis buffer (30 mM 
HEPES, pH7.4, 0.5% Triton X-100, 100 mM NaCl, 4 mM EDTA, 10 mM NaF, 50 µg/ml 
aprotinin, 100 µM leupeptin, 25 µM pepstatin A, and 2 mM PMSF) as described (Kubota et 
al., 2013). In vitro kinase assays were performed as described (Iwama et al., 1996; 
Yamaguchi et al., 2001; Kasahara et al., 2004; Matsuda et al., 2006). In brief, c-Src was 
immunoprecipitated from Triton X-100 lysates of COS-1 cells transfected with c-Src or 
c-Src(KD). Ku70-wt was immunoprecipitated from Triton X-100 lysates of COS-1 cells 
transfected with Ku70-wt. After washing, Ku70-wt was eluted with 0.2 M glycine-HCl buffer 
(pH 2.5) and immediately neutralized with 1 M Tris-HCl (pH 8.8). Equal amounts of c-Src 
immunoprecipitates bound to the beads were reacted with eluted Ku70-wt in kinase buffer 
(40 mM HEPES, pH 7.4, 0.1% Triton X-100, 5 mM MnCl2, 5 mM MgCl2, and 1 mM 
Na3VO4) containing 100 µM unlabeled ATP at 30°C for the indicated periods. 
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Results 
1. Tyrosine phosphorylation of Ku70 
We recently performed phosphoproteomic analyses of tyrosine-phosphorylated proteins 
in HeLa S3 cells overexpressing the Src-family kinase Lyn tagged with a nuclear localization 
signal (NLS-Lyn) (Kubota et al., 2013). Purified tyrosine-phosphorylated proteins using 
anti-phosphotyrosine (pTyr) antibody were digested with trypsin. I found that the 
tyrosine-phosphorylated peptides detected by LC/MS/MS contained Ku70, a ubiquitously 
expressed protein, as a candidate substrate of Src-family kinases. To verify tyrosine 
phosphorylation of endogenous Ku70, I treated HeLa S3 cells stably expressing NLS-Lyn 
(HeLa S3/NLS-Lyn) were treated with a high dose of the potent tyrosine phosphatase 
inhibitor Na3VO4, and immunoprecipitated endogenous Ku70 from cell lysates. Endogenous 
Ku70 was tyrosine-phosphorylated by NLS-Lyn (Figure 003). Furthermore, cells were 
cotransfected with wild-type Ku70 (Ku70-wt) plus c-Src or Ku70-wt plus c-Src(KD) and 
cultured in the presence or absence of the Src inhibitor PP2. I found that expressed Ku70-wt 
was tyrosine-phosphorylatedby c-Src but not c-Src(KD), and treatment with PP2 inhibited 
tyrosine phosphorylation of Ku70-wt (Figure 1A in my main publication). To examine 
whether the other Src members were able to phosphorylate Ku70 at tyrosine residues, I 
cotransfected cells with Ku70-wt in conjunction with Lyn, c-Src, or Fyn. Among Lyn, c-Src 
and Fyn, expression of c-Src was found to strongly induce tyrosine phosphorylation of Ku70 
(Figure 1B in my main publication). Furthermore, to test whether Ku70 was a direct substrate 
of c-Src, I transfected COS-1 cells with Ku70-wt, c-Src, or c-Src(KD), immunoprecipitated 
each protein, and performed in vitro kinase assays. Tyrosine phosphorylation of Ku70-wt by 
c-Src was detected in a kinase activity-dependent manner (Figure 1C and 1D in my main 
publication). These results suggest that c-Src directly tyrosine-phosphorylates Ku70. 
 
2. Tyrosine phosphorylation of Ku70 at Tyr530 
Our recent phosphoproteomic analysis (Kubota et al., 2013) showed a 
tyrosine-phosphorylated peptide of Ku70-phospho-Tyr530 (Figure 004). I generated a Ku70 
mutant that has a phenylalanine substitution for Tyr530 (Ku70-YF) (Figure 2A in my main 
publication). COS-1 cells were cotransfected with c-Src plus Ku70-wt or Ku70-YF. The level 
of tyrosine phosphorylation of Ku70-YF was decreased to approximately 56% of that of 
Ku70-wt (Figure 2B in my main publication). These results suggest that Tyr-530 is one of the 
major tyrosine phosphorylation sites of Ku70.  
 
3. Involvement of Src-family kinases and Ku70 in suppression of apoptosis 
Previous studies reported that Ku70 plays a role in suppression of apoptosis (Cohen et al., 
2004a; Cohen et al., 2004b; Subramanian et al., 2005; Mazumder et al., 2007; Subramanian et 
al., 2007; Dumitru et al., 2012). To understand the regulation of the ability of Ku70 to 
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suppress apoptosis, I established stable Ku70-knockdown cell lines (Figure 4A and 4B in my 
main publication). To examine the effect of Ku70 knockdown on UV-induced apoptosis, I 
treated parental HeLa S3 cells and HeLa S3/shKu70 cells with UV light and measured the 
percentage of apoptotic cells by staining for cleaved caspase-3 and/or nuclear 
condensation/fragmentation (Figure 4C in my main publication, Figure 005). In agreement 
with previous studies (Cohen et al., 2004a), an increase in UV-induced apoptosis was 
observed in Ku70 knockdown cells (Figure 4D in my main publication). 
To examine the involvement of Src-family kinases and Ku70 in UV-induced apoptosis, I 
treated parental HeLa S3 cells and HeLa S3/shKu70 cells with UV light in the presence or 
absence of PP2 or SU6656, another Src inhibitor. It was found that Src inhibition increased 
the level of apoptosis in parental HeLa S3 cells (Figure 4E in my main publication, open 
bars), but not in Ku70-knockdown cells (Figure 4E in my main publication, solid bars). To 
substantiate that the kinase activity of Src-family kinases was critical for suppression of 
apoptosis, parental HeLa S3 cells and HeLa S3/shKu70 cells transfected with the c-Src or 
Lyn were treated with UV light. I found that c-Src overexpression significantly suppressed 
UV-induced apoptosis in HeLa S3 cells (Figure 4F in my main publication, open bars) but 
not in Ku70-knockdown cells (Figure 4F in my main publication, solid bars). Taken together, 
these results suggest that Src-family kinases suppress UV-induced apoptosis through Ku70.  
 
4. Inability of Src-family kinases to be activated upon UV irradiation 
To examine whether Src-family kinases were activated by UV irradiation, 
autophosphorylation levels of endogenous Src-family kinases were detected by Western 
blotting with anti-Src[pY416] antibody. Cells were starved for 20 h and then treated with 
EGF. EGF stimulation for 5 min strongly induced autophosphorylation of endogenous 
Src-family kinases and increased the levels of tyrosine phosphorylation of cellular proteins, 
including ERK kinases (Figure 5A in my main publication). In contrast, UV irradiation did 
not increase those of tyrosine phosphorylation (Figure 5B in my main publication). 
Furthermore, those of tyrosine phosphorylation was decreased by PP2 treatment (Figure 5C 
in my main publication). These results suggest that the basal level of endogenous Src activity 
is maintained under normal culture conditions and is not increased by UV irradiation.  
 
5. Contribution of Src members to suppression of apoptosis 
To verify tyrosine phosphorylation of endogenous Ku70, I treated cells with or without 
UV light in the presence of pervanadate, an extremely potent protein-tyrosine phosphatase 
inhibitor. I immunoprecipitated endogenous Ku70 with anti-Ku70 antibody and succeeded in 
detecting tyrosine phosphorylation of endogenous Ku70 irrespective of UV irradiation 
(Figure 6A in my main publication). Importantly, tyrosine phosphorylation of endogenous 
Ku70 was inhibited by treatment with PP2 (Figure 6A in my main publication). Furthermore, 
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I examined the effect of knockdown of Src members on the level of tyrosine phosphorylation 
of Ku70 and apoptosis in HeLa S3 cells. c-Src knockdown decreased the level of tyrosine 
phosphorylation of Ku70 (Figure 6B in my main publication), and significantly increased the 
levels of UV- and Adriamycin -induced apoptosis (Figure 6C in my main publication). We 
recently established a HeLa S3 cell line stably expressing shRNA against Lyn and/or Fyn 
(Morinaga et al., 2014). I immunoprecipitated endogenous Ku70 from Fyn-knockdown cells 
and Lyn-knockdown cells and found that the levels of tyrosine phosphorylation of 
endogenous Ku70 were slightly decreased by Fyn knockdown but rather increased by Lyn 
knockdown (Figure 6D in my main publication). In contrast to single knockdown of Fyn or 
Lyn, Fyn/Lyn double-knockdown markedly decreased the levels of tyrosine phosphorylation 
of endogenous Ku70 (Figure 6D in my main publication). Furthermore, the levels of UV- and 
Adriamycin-induced apoptosis were significantly increased by Fyn/Lyn double-knockdown 
(Figure 6E in my main publication). Taken together, these results suggest that c-Src, Fyn and 
Lyn, the major Src members in HeLa S3 cells, play a redundant role in tyrosine 
phosphorylation of Ku70 and suppression of apoptosis. 
 
6. Role for tyrosine phosphorylation of Ku70 at Tyr-530 in suppression of apoptosis 
Replacement of a tyrosine residue with a glutamic acid residue would exert a 
phosphomimetic effect owing to its negative charge. To examine the role of tyrosine 
phosphorylation of Ku70 at Tyr-530 in suppression of apoptosis, I established HeLa S3 cell 
lines stably expressing tetracycline-inducible Ku70-wt, its nonphosphorylatable YF mutant, 
or its phosphomimetic YE mutant. These cells were treated with doxycycline for induction of 
Ku70-wt, Ku70-YF, or Ku70-YE, and then irradiated with UV (Figure 7A in my main 
publication) (Figure 006). Expression of Ku70-wt suppressed UV-induced apoptosis (Figure 
7B in my main publication), in agreement with previous studies (Cohen et al., 2004a). 
Notably, expression of Ku70-YE suppressed UV-induced apoptosis to a similar extent to that 
of Ku70-wt, but expression of Ku70-YF could not suppress UV-induced apoptosis so much 
(Figure 7B in my main publication). In the presence of PP2, there was no difference in the 
levels of apoptosis between Ku70-wt-expressing cells and Ku70-YF-expressing cells (Figure 
7C in my main publication). To confirm these results, I transiently rescued HeLa S3/shKu70 
cells with Ku70-wt and its nonphosphorylatable YF mutant, or its phosphomimetic YE 
mutant (Figure 7D in my main publication), and found that similar results were observed in 
HeLa S3/shKu70 cells upon treatment with UV or Adriamycin (Figure 7E, 7F and 7G in my 
main publication). These results suggest that tyrosine phosphorylation of Ku70 at Tyr-530 
plays a role in suppression of apoptosis. 
Next, apoptosis can be initiated by activation of the proapoptotic factor Bax (Scorrano 
and Korsmeyer, 2003; Tait and Green, 2003), and Ku70 suppresses Bax-mediated apoptosis 
by sequestering Bax away from mitochondria through the Ku70–Bax interaction (Cohen et al., 
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2004a; Cohen et al., 2004b; Subramanian et al., 2005; Mazumder et al., 2007; Subramanian et 
al., 2007; Dumitru et al., 2012). Cotransfection of Bax with control vector, c-Src, or v-Src, a 
highly activated variant of c-Src, showed that the levels of Bax-mediated apoptosis were 
decreased by expression of c-Src and v-Src (Figure 7H in my main publication). To examine 
the effect of tyrosine phosphorylation of Ku70 at Tyr-530 on Bax-induced apoptosis, HeLa 
S3 cells inducibly expressing v-Src were transfected with Bax plus Ku70-wt or Bax plus 
Ku70-YF (Figure 7I in my main publication). Expression of Ku70-wt suppressed 
Bax-induced apoptosis (Figure 7I in my main publication), in agreement with previous 
studies (Cohen et al., 2004a). In contrast, expression of Ku70-YF showed a significant 
reduction in suppression of Bax-induced apoptosis compared with that of Ku70-wt (Figure 7I 
in my main publication). Taken together, these results suggest that Src-mediated 
phosphorylation of Ku70 at Tyr-530 is important for suppression of Bax-mediated apoptosis. 
 
7. Role of Ku70 phosphorylation at Tyr-530 in acetylation of Ku70 
Previous studies reported that the multiple lysine residues in Ku70 are acetylated, and 
that acetylation of Ku70 in the C-terminal flexible linker region adjacent to the 
Bax-interaction domain chiefly contributes to promote apoptosis by possible inactivation of 
the Ku70’s Bax-interaction domain (Cohen et al., 2004a; Cohen et al., 2004b; Subramanian et 
al., 2005; Subramanian et al., 2007). My findings demonstrate that phosphorylation of Ku70 
at Tyr-530 is important for suppression of apoptosis (Figure 7 in my main publication) and 
that the phosphorylation site of Ku70 is located close to the possible acetylation sites in the 
C-terminal flexible linker region (Figure 2 in my main publication), leading to the intriguing 
hypothesis that tyrosine phosphorylation of Ku70 interferes with acetylation of Ku70. To 
examine the levels of Ku70 acetylation upon UV irradiation, cells expressing Ku70-wt were 
treated with UV light in the presence or absence of PP2 and performed immunoprecipitation 
assays using anti-myc antibody. I found that Src inhibition enhanced the level of acetylation 
of Ku70-wt upon UV irradiation (Figure 8A and 8B in my main publication). Conversely, I 
immunoprecipitated Ku70-wt with anti-acetylated lysine antibody from cells expressing 
Ku70-wt (Figure 5C in my main publication) and confirmed that acetylation of Ku70-wt is 
increased by Src inhibition upon UV irradiation (Figure 5D and 5E in my main publication). 
These results suggest that Src-mediated tyrosine phosphorylation of Ku70 inhibits acetylation 
of Ku70. Next, I assessed the levels of acetylation of Ku70-wt and Ku70-YE upon UV 
irradiation. I immunoprecipitated Ku70-wt or Ku70-YE with anti-acetylated lysine antibody 
from HeLa S3 cells inducibly expressing Ku70-wt or Ku70-YE, and found that expression of 
Ku70-YE significantly decreased the level of its acetylation compared with that of Ku70-wt 
(Figure 007). Furthermore, by means of knockdown-rescue, I examined the levels of 
acetylation of Ku70-wt and Ku70-YF upon UV irradiation (Figure 8F in my main 
publication). Notably, expression of Ku70-YF significantly enhanced the level of its 
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acetylation compared with that of Ku70-wt (Figure 8G in my main publication). These results 
suggest that the level of phosphorylation at Tyr-530 on Ku70 is inversely correlated with the 
level of Ku70 acetylation.   
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Discussion 
 
Ku70 is known to suppress apoptosis by negatively regulating Bax activation (Cohen et 
al., 2004a; Cohen et al., 2004b; Subramanian et al., 2005; Mazumder et al., 2007; 
Subramanian et al., 2007; Dumitru et al., 2012). Upon apoptotic stimulation, acetylation of 
Ku70 in the C-terminal flexible linker region results in activating Bax, thereby promoting 
apoptosis (Cohen et al., 2004a; Cohen et al., 2004b; Subramanian et al., 2005; Subramanian 
et al., 2007).  
In the present study, I provide evidence that Src-family kinases act as an effector for 
Ku70-dependent suppression of apoptosis. First, Src-family kinases phosphorylate Ku70 at 
Tyr-530. Second, Ku70 knockdown impairs c-Src-mediated suppression of apoptosis, Third, 
phosphorylation of Ku70 at Tyr-530 suppresses UV-, Adriamycin- or Bax-induced apoptosis. 
Fourth, inhibition of the activity of endogenous Src-family kinases increases the level of 
Ku70 acetylation. Fifth, Ku70 mutation at Tyr-530 to phenylalanine enhances acetylation of 
Ku70. 
Thus, I present a model for reduced apoptotic susceptibility by Src-family kinases 
(Figure 8 in my main publication). Src-family kinases phosphorylate Ku70 at Tyr-530, which 
is located close to the possible acetylation sites in the C-terminal flexible linker region 
(Cohen et al., 2004a). Phosphorylation of Ku70 at Tyr-530 decreases acetylation of Ku70, 
resulting in a reduction in susceptibility to apoptotic stimuli. Inhibition of the activity of 
Src-family kinases decreases phosphorylation of Ku70 at Tyr-530 and concomitantly 
enhances the level of acetylation of Ku70, thereby promoting Bax-mediated apoptosis. My 
results suggest the intriguing possibility that endogenous Src activity raises the cellular 
threshold to apoptotic stimuli through tyrosine phosphorylation of Ku70 in every cell. Taken 
together with ubiquitous expression of Src-family kinases and Ku70, I hypothesize that 
Src-family kinase is a safety device for Ku70-mediated apoptosis to protect our bodies from 
hyperactive apoptotic cell death.  
I show that the levels of Ku70 acetylation is enhanced by Src inhibition (Figure 8A, 8B, 
8D and 8E in my main publication) and by the mutation of Ku70 at Tyr-530 to phenylalanine 
(Figure 8F and 8G in my main publication). Previous studies reported that Ku70 is acetylated 
at multiple sites, including the sites located in the C-terminal flexible linker region and the 
DNA binding domain (Cohen et al., 2004a, Chen et al., 2007), and that acetylation of Ku70 in 
the C-terminal flexible linker region negatively regulates Ku70-mediated suppression of 
apoptosis (Cohen et al., 2004a; Cohen et al., 2004b; Subramanian et al., 2005; Subramanian 
et al., 2007). Ku70 is acetylated by the acetyltransferases CBP and PCAF (Cohen et al., 
2004a, Subramanian et al., 2007) and deacetylated by the deacetylases SIRT1, SIRT3, and 
HDAC6 (Cohen et al., 2004b; Sundaresan et al., 2008; Subramanian et al., 2011). It should be 
emphasized that Src-mediated phosphorylation of Ku70 at Tyr-530 decreases the levels of 
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Ku70 acetylation, leading to suppression of apoptosis (Figures 7 and 8 in my main 
publication). There is no report about the interaction between phosphorylation and acetylation 
of Ku70 in apoptosis thus far. The crosstalk between phosphorylation and acetylation has 
been documented among histone and non-histone proteins (Latham and Dent, 2007; Yang and 
Seto, 2008; Choudhary et al., 2014). Considering that the phosphorylation site of Ku70 at 
Tyr-530 is located close to the C-terminal flexible linker region (Figures 2 in my main 
publication), I hypothesize that phosphorylation at Tyr-530 may promote the association of 
Ku70 with deacetylases or may weaken the association of Ku70 with acetyltransferases. 
Further experiments are needed to fully understand the relationship between tyrosine 
phosphorylation and acetylation on Ku70. 
Src-family kinases are overexpressed and activated in various human cancers and play 
important roles in cancer development, progression, and resistance to anticancer therapy 
(Blume-Jensen and Hunter, 2001; Yeatman, 2004; Kim et al., 2009; Zhang and Yu, 2012). My 
results suggest that, upon UV treatment, high expression of c-Src markedly reduces 
susceptibility to apoptosis (Figure 4F in my main publication). I further show that inhibition 
of Tyr-530 phosphorylation enhances susceptibility to apoptosis (Figure 7 in my main 
publication), leading to the promising possibility that development of inhibitors for tyrosine 
phosphorylation of Ku70 might potentiate the sensitivity of cancer cells to anticancer therapy. 
In conclusion, I identify Ku70 as a substrate of Src-family kinases. This is a first report 
of the significance of Src-mediated phosphorylation of Ku70 at Tyr-530 in suppression of 
apoptosis. Further studies will be needed to understand the relationship between tyrosine 
phosphorylation of Ku70 and cancer cell survival or therapeutic resistance. 
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Figures  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 001. Src-mediated tyrosine phosphorylation.  
pY, phosphorylated tyrosine residues. 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 002. A schematic representation of Src.  
SH, Src homology domain; Kinase, the tyrosine kinase domain. 
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Figure 003. Tyrosine phosphorulation of endogenous Ku70 in NLS-Lyn expressing cells. 
Parental HeLa S3 cells or HeLa S3/NLS-Lyn were treated with sodium orthovanadate 
(Na3VO4). Endogenous Ku70 was immunoprecipitated (IP) with anti-Ku70 antibody. Western 
blotting was performed with the indicated antibodies. 
 
 
 
 
 
 
 
 
 
 
 
Figure 004. A sequence of Ku70 phosphopeptide detected by phosphoproteomic 
analysis. 
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Figure 005. Quantification for UV-induced apoptosis. 
HeLa S3 cells were treated with UV light and cultured for 12 h. After fixation, cells were 
stained with propidium iodide for DNA. Arrowheads indicate cells showing apoptotic DNA 
fragmentation/condensation. 
 
 
 
 
 
 
 
 
 
Figure 006. Role of Ku70 phosphorylation at Tyr-530 in suppression of apoptosis. 
HeLa S3/TR cells inducibly expressing myc-Ku70-wt, myc-Ku70-YF, or myc-Ku70-YE were 
incubated with doxycycline for 24 h, and then irradiated with 100 J/m2 UV. At 12 h after UV 
irradiation, cells were fixed and doubly stained with anti-myc antibody and propidium iodide. 
Arrowheads indicate cells showing apoptotic DNA fragmentation/condensation.  
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Figure 007. Role of Ku70 phosphorylation at Tyr-530 in acetylation. 
HeLa S3/TR cells inducibly expressing myc-Ku70-wt or myc-Ku70-YE were incubated with 
doxycycline for 24 h, and then irradiated with 100 J/m2 UV. At 12 h after UV irradiation, 
acetylated Ku70-wt or Ku70-YE was immunoprecipitated with anti-acetylated lysine 
antibody. Western blotting was performed with anti-myc and anti-α-tubulin antibodies. 
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Tables 
 
Table 1. Primer list for proteins 
 
 
Table 2. Primer list for Ku70 mutants  
 
 
Table 3. Nucleotides list for shRNA 
 
 
  
shRNA target sequence (5'-3')
Ku70 shRNA-3’UTR GAAGAGTCTACCCGACATAAG
Ku70 shRNA-CDS GATGAGTCATAAGAGGATCAT
Lyn shRNA GGACAGAGGTTTCAAACTA (Morinaga et al., 2014)
Fyn shRNA GGAAGAGCTCTGAAATTAC (Morinaga et al., 2014)
c-Src shRNA GCTCCAGATTGTCAACAAC (Sasaki et al., 2014)
Forward primer (5'-3') Reverse primer (5'-3')
Ku70-YF
TGGATGAGTTTAAGGAACTAGTTTTCCCAC
CAGATTACAATCCTGAAGG
TGTAATCTGGTGGGAAAACTAGTTCCTTAA
ACTCATCCACCAAGGAGCC
Ku70-YE
TGGATGAGTTTAAGGAGCTTGTTGAGCCTCC
GGATTACAATCCTGAAGG
TGTAATCTGGTGGCTCAACAAGCTCTTTAA
ACTCATCCACCAAGGAGCC
Ku70-(shRNA)-
resistant
TGATGTCCAATTTAAAATGTCTCACAAACG
AATCATGCTGTTCACCAATG
ACAGCATGATTCGTTTGTGAGACATTTTAA
ATTGGACATCACTAAAGAGG
Forward primer (5'-3') Reverse primer (5'-3')
Ku70
GAGTCGGATCCTTAAGCAGTGGAATGTCAG
GGTGGGAGTC
GAATAGGGCCCATCTCGAGTCAGTCCTGGA
AGTGCTTGG
Bax
ACTGAATTCAGTGGAGGTATGGACGGGTCC
GGGGAGCAGCCCAG
CAGTCTCGAGTCAGCCCATCTTCTTCCAGAT
GGTGAGTGAGGC
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Table 4. Antibodies 
 
 
 
　Antibodies Types Source
Upstate Biotechnology, Inc
(Tamura et al., 2000)
Lyn (H6) mouse monoclonal Santa Cruz Biotechnology
Lyn9 mouse monoclonal
Wako Pure Chemical Industries,
Osaka
Src (GD11) mouse monoclonal Millipore
actin (C4) mouse monoclonal CHEMICON International
Ku70 (N3H10) mouse monoclonal Santa Cruz Biotechnology
acetylated-lysine (Ac-K-103) mouse monoclonal Cell Signaling Technology
Flag (M2) mouse monoclonal Sigma-Aldrich
acetylated-lysine rabbit monoclonal Cell Signaling Technology
ß-actin (13E5) rabbit monoclonal Cell Signaling Technology
phospho-p44/42 MAPK Thr202/Tyr204
(pERK1/2) (D13.14.4E)
rabbit monoclonal Cell Signaling Technology
Src (EPR5496). rabbit monoclonal Abcam
Ku70 rabbit polyclonal Millipore
cleaved caspase-3 (Asp175) rabbit polyclonal Cell Signaling Technology
Flag rabbit polyclonal Sigma-Aldrich
Src[pY416] (phospho-Src family
(Tyr416)
rabbit polyclonal Cell Signaling Technology
ERK2 (C14) rabbit polyclonal Santa Cruz Biotechnology
Lyn (Lyn44) rabbit polyclonal Santa Cruz Biotechnology
HA (Y11) rabbit polyclonal Santa Cruz Biotechnology
Fyn (Fyn3) rabbit polyclonal Santa Cruz Biotechnology
Src (N16) rabbit polyclonal Santa Cruz Biotechnology
myc (A14) rabbit polyclonal Santa Cruz Biotechnology
myc rabbit polyclonal Abcam
myc (A14-G) goat polyclonal Santa Cruz Biotechnology
HA (Y11-G) goat polyclonal Santa Cruz Biotechnology
Flag goat polyclonal Novus Biologicals
α-tubulin rat polyclonal Serotec
phosphotyrosine (pTyr) (4G10) mouse monoclonal
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Table 5. Cell line used in this study 
  
   
　Cell line Types Source
HeLa S3 HeLa S3
Japanese Collection of Research
Bioresources, Osaka
COS-1 COS-1
Japanese Collection of Research
Bioresources, Osaka
HeLa S3/TR HeLa S3 Aoyama et al., 2011
HeLa S3/TR/v-Src HeLa S3/TR Soeda et al., 2013
HeLa S3/TR/c-Src-HA HeLa S3/TR Nakayama et al., 2012
HeLa S3/sh(Fyn) HeLa S3 Morinaga et al., 2014
HeLa S3/sh(Lyn) HeLa S3 Morinaga et al., 2014
HeLa S3/sh(Fyn)+sh(Lyn)  HeLa S3 Morinaga et al., 2014
HeLa S3/NLS-Lyn HeLa S3 Kubota et al., et al., 2013
HeLa S3/shKu70 HeLa S3 This study
HeLa S3/TR/myc-Ku70-wt HeLa S3/TR This study
HeLa S3/TR/myc-Ku70-YF HeLa S3/TR This study
HeLa S3/TR /myc-Ku70-YE HeLa S3/TR This study
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